Thijs van Schaik

4PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 16, 2025
Antitumor Immunity Mediated by Engineered Stem Cells Exploiting TRAIL-Induced Cell Death and FLT3L Immunomodulation.

Thijs A van Schaik, Kok-Siong Chen, Nobuhiko Kanaya

|Aug 01, 2023
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138.

Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel

|May 31, 2023
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.

Nobuhiko Kanaya, Yohei Kitamura, Maria Lopez Vazquez

|Jan 04, 2023
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity.

Kok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik

Pageof 1